NCT04627077View on ClinicalTrials.gov

Livestrong Cancer Institutes' Patient Reported Outcomes Study

CompletedOBSERVATIONAL
Enrollment

121

Participants

Timeline

Start Date

January 22, 2018

Primary Completion Date

January 25, 2019

Study Completion Date

January 25, 2019

Conditions
NeoplasmsDrug Therapy
Trial Locations (1)

78701

Dell Seton Medical Center, Austin

All Listed Sponsors
lead

University of Texas at Austin

OTHER

NCT04627077 - Livestrong Cancer Institutes' Patient Reported Outcomes Study | Biotech Hunter | Biotech Hunter